Epacadostat plus pembrolizumab versus placebo plus pembrolizumab for advanced urothelial carcinoma: results from the randomized phase III ECHO-303/KEYNOTE-698 study.

Irfan CicinElizabeth R PlimackHoward GurneyRaya LeibowitzBoris Y AlekseevFrancis X ParnisAvivit PeerAndrea NecchiJoaquim BellmuntHiroyuki NishiyamaJason ClarkMihaela MunteanuRitesh KatariaCalvin JiaThomas PowlesCora N Sternberg

Published in: BMC cancer (2024)

ClinicalTrials.gov, NCT03374488. Registered 12/15/2017.

Keyphrases

phase iii
open label
double blind
phase ii
placebo controlled
clinical trial
advanced non small cell lung cancer
magnetic resonance
study protocol
magnetic resonance imaging
computed tomography
diffusion weighted imaging
contrast enhanced
epidermal growth factor receptor
tyrosine kinase